HROW Q1 2020 Earnings — Harrow Health, Inc. Revenue & Financial Results | Market Cap Arena

HROWHarrow Health, Inc.

$1B

Q1 2020 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$12M-3.8% YoY

Gross Profit

$8M69.3% margin

Operating Income

-$628,000-5.3% margin

Net Income

-$13M-109.2% margin

EPS (Diluted)

$-0.50

QoQ Revenue Growth

-6.2%

Cash Flow

Operating Cash Flow

-$550,000

Free Cash Flow

-$823,000

Stock-Based Comp.

$533,000

Balance Sheet

Total Assets

$47M

Total Liabilities

$32M

Stockholders' Equity

$15M

Cash & Equivalents

$4M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$12M	$12M	-3.8%
Gross Profit	$8M	$8M	-2.4%
Operating Income	-$628,000	-$556,000	-12.9%
Net Income	-$13M	$11M	-213.6%

Revenue Segments

License Revenues

$7,000100%